Abstract:Background and PurposeOsteosarcoma, a primary malignant bone tumour prevalent among adolescents and young adults, remains a considerable challenge despite protracted progress made in enhancing patient survival rates over the last 40 years. Consequently, the development of novel therapeutic approaches for osteosarcoma is imperative. Sanguinarine (SNG), a compound with demonstrated potent anticancer properties against various malignancies, presents a promising avenue for exploration. Nevertheless, the intricate molecular mechanisms underpinning SNG's actions in osteosarcoma remain elusive, necessitating further elucidation. Experimental ApproachSingle-stranded DNA-binding protein 1 (SSBP1) was screened out by differential proteomic analysis. Apoptosis, cell cycle, reactive oxygen species (ROS) and mitochondrial changes were assessed via flow cytometry. Western blotting and quantitative real-time reverse transcription PCR (qRT-PCR) were used to determine protein and gene levels. The antitumour mechanism of SNG was explored at a molecular level using chromatin immunoprecipitation (ChIP) and dual luciferase reporter plasmids. Key ResultsOur investigation revealed that SNG exerted an up-regulated effect on SSBP1, disrupting mitochondrial function and inducing apoptosis. In-depth analysis uncovered a mechanism whereby SNG hindered the JAK/signal transducer and activator of transcription 3 (STAT3) signalling pathway, relieved the inhibitory effect of STAT3 on SSBP1 transcription, and inhibited the downstream PI3K/Akt/mTOR signalling axis, ultimately activating apoptosis. Conclusions and ImplicationsThe study delved further into elucidating the anticancer mechanism of SNG in osteosarcoma. Notably, we unravelled the previously undisclosed apoptotic potential of SSBP1 in osteosarcoma cells. This finding holds substantial promise in advancing the development of novel anticancer drugs and identification of therapeutic targets.

Sanguinarine Protects Against Ovariectomy-Induced Osteoporosis in Mice

Anti-osteoporosis Activity of Sanguinarine in Preosteoblast MC3T3-E1 Cells and an Ovariectomized Rat Model.

Administration of SB239063 Ameliorates Ovariectomy-Induced Bone Loss Via Suppressing Osteoclastogenesis in Mice

Sanguinarine Inhibits Osteoclast Formation and Bone Resorption Via Suppressing RANKL-induced Activation of NF-κB and ERK Signaling Pathways.

Sanguinarine Protects Against Pressure Overload-Induced Cardiac Remodeling Via Inhibition Of Nuclear Factor-Kappa B Activation

Sanguinarine protects against pressure overload‑induced cardiac remodeling via inhibition of nuclear factor-κB activation

Mangiferin promotes osteogenic differentiation and alleviates osteoporosis in the ovariectomized mouse via the AXL/ERK5 pathway

Sanguinarine combats hypoxia-induced activation of EphB4 and HIF-1α pathways in breast cancer

Bioactivity and mechanism of action of sanguinarine and its derivatives in the past 10 years

Naringin improves bone properties in ovariectomized mice and exerts oestrogen-like activities in rat osteoblast-like (UMR-106) cells.

Effect of Sanguinarine on the Growth and Radiosensitivity of Human Ovarian Cancer Cells

The anti-inflammatory effects of sanguinarine and its modulation of inflammatory mediators from peritoneal macrophages.

Vindoline Inhibits RANKL-Induced Osteoclastogenesis and Prevents Ovariectomy-Induced Bone Loss in Mice

Effects of Sangu Decoction on Osteoclast Activity in a Rat Model of Breast Cancer Bone Metastasis

Sanguinarine is a Novel VEGF Inhibitor Involved in the Suppression of Angiogenesis and Cell Migration.

The anticancer effect of Sanguinarine, a review.

Sanguinarine Disrupts the Colocalization and Interaction of HIF‐1α with Tyrosine and Serine Phosphorylated‐stat3 in Breast Cancer

Protective effect of sanguinarine against acetic acid-induced ulcerative colitis in mice.

Sanguinarine Regulates Tumor-Associated Macrophages to Prevent Lung Cancer Angiogenesis Through the WNT/β-Catenin Pathway

Sanguinarine Represses the Growth and Metastasis of Non-small Cell Lung Cancer by Facilitating Ferroptosis

Sanguinarine Induces Apoptosis in Osteosarcoma by Attenuating the Binding of STAT3 to the Single-Stranded DNA-binding Protein 1 (SSBP1) Promoter Region